Solventum Corporation (SOLV)

Form 8-K - Current report

Form SD - Specialized disclosure report

Form 8-K - Current report

Solventum to Participate in the 2026 Jefferies Healthcare Conference

Solventum to Participate in the 2026 Jefferies Healthcare Conference PR Newswire EAGAN, Minn., May 27...

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Solventum to Participate in the 2026 BofA Securities Health Care Conference

Solventum to Participate in the 2026 BofA Securities Health Care Conference PR Newswire ST. PAUL, Minn...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Solventum Reports First Quarter 2026 Financial Results

Solventum Reports First Quarter 2026 Financial Results PR Newswire EAGAN, Minn., May 5, 2026 Reported...

Trian Calls on Solventum's Board to Create Value; Publishes Open Letter and Slide Deck

Solventum's Spin-Out from 3M has Maximized Executive Compensation, Not Shareholder Value Outlines Three...

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, 2026

Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, 2026 PR Newswire ST. PAUL, Minn., April...